Microbiome-Targeted Reduction of Circulating Trimethylamine N-Oxide Mitigates Ischemic Stroke Risk
Jin Sun You, Chai Jung Yoon, June Beom Kim, Mohammed Abd Alrahman, Hee Yong Jung, Mi Young Yoon, Y. Kim, Sang-Guk Lee, Hyo Suk Nam, Sang Sun Yoon
This study identifies Paracoccus aminovorans BM109 as a microbiome-targeted therapy that reduces TMAO levels and mitigates ischemic stroke risk in animal models.
bioRxiv · Apr 16, 2026 · PreprintMicrobiology